DSGN · CIK 0001807120 · FY2025 live · 2025-12-31
Design Therapeutics, Inc.
View as
Model
Classic Z
FY2025
7.43
Zone
Safe
Prior
—
Market DD
—
1y PD
—
7.43
Z″ 15.76
Score 7.43 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.931.2 × = 1.12X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−1.311.4 × = −1.84X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.353.3 × = −1.16X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
15.510.6 × = 9.31X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.
Meridian Rank
72.27
0–100 · Classic Z family
Book standing
96
Year change
—
Market PD
—
O-score
9
Events on this name
Same published rows as Today.
Approaching grey
watch · 41
- Live score: — → 7.43
- Cut: — → 1.80
Overview
rule-v1
Design Therapeutics, Inc. is on classic Z at 7.43 (safe) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Safe; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 94th percentile in Healthcare.
Filing line items
Current assets
$224M
Total assets
$226M
Current liabilities
$13M
Total liabilities
$14M
Working capital
$211M
Retained earnings
−$297M
EBIT
−$79M
Total sales
$0
Book equity
$213M
Accession 0001193125-26-098491. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 14 Sept 2026.